News & Blog

Tag Archives: FDA

Glossary Blog, February 2018: CAR T-Cell Therapy

CAR T-cell Therapy: A type of treatment in which a patient’s T-cells (a type of immune system cell) are changed in the laboratory so they will attack cancer cells. T-cells are taken from a patient’s blood. Then the gene for a special receptor that binds to a certain protein on the patient’s cancer cells is […]

What the Brain Tumor Community Was Reading in 2017

This year we covered many topics on this blog, from stories of strength, determination, and dedication in the community; to news on research progress; clinical trial results and updates; innovation; and FDA approvals. We saw glioblastoma again enter the national consciousness, with the unfortunate news of Senator John McCain’s diagnosis (see below), as well as some […]

Top Five Blogs: July – September 2017

July and August are prime months to get away for a break, relax, and enjoy the summer vacation season. And September welcomes everyone back to the ‘real world’ of school, sports, and normal work schedules. While unfortunately, we can’t afford to ‘take a break’ in the brain tumor community – just as patients and caregivers […]

Share